Sudarshan Pharma has approved the acquisition of a 9.5% stake in US-based MedTherapy Biotechnology, expanding its exposure to oncology cell and gene therapy.

The FDA has granted accelerated approval to Etcamah in combination with a CDK4/6 inhibitor for adults with ESR1-mutated HR-positive, HER2-negative locally advanced or metastatic breast cancer.

Novartis India is looking at therapy-aligned acquisition opportunities while seeking to deepen its presence in India's Tier 2 and Tier 3 markets.

Novartis reports that the Phase III Lp(a)HORIZON study of pelacarsen did not meet its primary cardiovascular endpoint in patients with elevated lipoprotein(a) and established cardiovascular disease.

Average annual compensation for US otolaryngologists reached $549,810 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in ENT.

Average annual compensation for US anesthesiologists reached $557,131 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty.

Average annual compensation for US urologists reached $566,740 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty.

Average annual compensation for US vascular surgeons reached $600,520 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty.

Average annual compensation for US cardiologists reached $604,635 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty.

Average annual compensation for US gastroenterologists reached $531,345 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in gastroenterology.

Average annual compensation for US oncologists reached $519,715 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in oncology.

Average annual compensation for US general surgeons reached $501,003 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in general surgery.

Average annual compensation for US dermatologists reached $497,509 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in dermatology.

Average annual compensation for US radiologists reached $609,684 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty.

Average annual compensation for US radiation oncologists reached $613,837 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty.

Average annual compensation for US plastic surgeons reached $625,757 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty.

Average annual compensation for US colon and rectal surgeons reached $492,802 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty.

Average annual compensation for US ophthalmologists reached $487,438 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in ophthalmology.

Average annual compensation for US hematologists reached $446,700 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in hematology.

Average annual compensation for US pulmonologists reached $441,472 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in pulmonology.